Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
05 2020
Historique:
received: 22 08 2019
revised: 08 11 2019
accepted: 15 11 2019
pubmed: 15 1 2020
medline: 20 9 2020
entrez: 15 1 2020
Statut: ppublish

Résumé

To study the demographics of Leber's hereditary optic neuropathy (LHON) using a large international database of people affected by LHON. Cross-sectional study. One thousand five hundred seventeen people affected by LHON with a known pathogenic genetic mutation. Self-reported genetic and demographic data were collected. The data were de-identified and then analyzed. Leber's hereditary optic neuropathy mutation, gender, age at vision loss onset, and geographical region. The data showed that both females and males can experience symptom onset at any age. We found a 3:1 male-to-female ratio. Interestingly, at younger than 5 years and older than 45 years, the male-to-female ratio of those becoming affected was approximately 1:1. A dramatic peak in age at onset of vision loss was found among males between 14 and 26 years of age. Disease onset in females occurred across all age groups, without any comparable dramatic peak of onset age. This study found that 10% of individuals become affected with LHON after 50 years of age. According to the literature, we found that the m.11778, m.14484, and m.3460 mutations were the most common LHON point mutations in both males and females, with a similar age at onset distribution. This was the largest study of LHON demographics to date. It showed that women carrying an LHON mutation are at higher risk of losing vision than is generally expected. Unlike the traditional 5:1 male-to-female ratio commonly reported in the literature, we found a 3:1 male-to-female ratio. Earlier studies may have harbored an ascertainment bias of overemphasizing the confirmation of this being a disease of young men. However, our data suggest that LHON is a disease that affects both females and males of all ages. This should prompt physicians to conduct genetic testing for LHON in all patients who meet the clinical criteria, regardless of whether they fit the demographics traditionally associated with the disease. Counseling about LHON should be offered to all maternal bloodline relatives, females and males of all ages, because they are at risk of sudden-onset legal blindness.

Identifiants

pubmed: 31932089
pii: S0161-6420(19)32295-X
doi: 10.1016/j.ophtha.2019.11.014
pii:
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

679-688

Informations de copyright

Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Lissa Poincenot (L)

LHON Project.

Alexander L Pearson (AL)

The Ottawa Eye Institute, University of Ottawa, Ottawa Canada. Electronic address: apear053@uottawa.ca.

Rustum Karanjia (R)

The Ottawa Eye Institute, University of Ottawa, Ottawa Canada; Ottawa Hospital Research Institute, Ottawa, Canada; Doheny Eye Institute, University of California-Los Angeles, Los Angeles, California; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH